Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1051494.RAX4ylIIGlkPNi9TY9QVQ3SFX0fA2K5gyy8HmZoHhRV1A130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1051494.RAX4ylIIGlkPNi9TY9QVQ3SFX0fA2K5gyy8HmZoHhRV1A130_assertion type Assertion NP1051494.RAX4ylIIGlkPNi9TY9QVQ3SFX0fA2K5gyy8HmZoHhRV1A130_head.
- NP1051494.RAX4ylIIGlkPNi9TY9QVQ3SFX0fA2K5gyy8HmZoHhRV1A130_assertion description "[Genetic mutations, such as activation of the KRAS2 oncogene, inactivation of the tumor-suppressor gene CDKN2A, inactivation of the tumor-suppressor gene TP53 and deleted in pancreatic cancer 4 (DPC4) gene defects are seen in those with pancreatic cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1051494.RAX4ylIIGlkPNi9TY9QVQ3SFX0fA2K5gyy8HmZoHhRV1A130_provenance.
- NP1051494.RAX4ylIIGlkPNi9TY9QVQ3SFX0fA2K5gyy8HmZoHhRV1A130_assertion evidence source_evidence_literature NP1051494.RAX4ylIIGlkPNi9TY9QVQ3SFX0fA2K5gyy8HmZoHhRV1A130_provenance.
- NP1051494.RAX4ylIIGlkPNi9TY9QVQ3SFX0fA2K5gyy8HmZoHhRV1A130_assertion SIO_000772 23393682 NP1051494.RAX4ylIIGlkPNi9TY9QVQ3SFX0fA2K5gyy8HmZoHhRV1A130_provenance.
- NP1051494.RAX4ylIIGlkPNi9TY9QVQ3SFX0fA2K5gyy8HmZoHhRV1A130_assertion wasDerivedFrom befree-2016 NP1051494.RAX4ylIIGlkPNi9TY9QVQ3SFX0fA2K5gyy8HmZoHhRV1A130_provenance.
- NP1051494.RAX4ylIIGlkPNi9TY9QVQ3SFX0fA2K5gyy8HmZoHhRV1A130_assertion wasGeneratedBy ECO_0000203 NP1051494.RAX4ylIIGlkPNi9TY9QVQ3SFX0fA2K5gyy8HmZoHhRV1A130_provenance.